SNDX

Up next

Next earnings call

Jul 30, 2026 Est · unconfirmed · in 2 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Apr 30, 2026

Equibles Rating blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 17.2 · elevated Equity put/call 0.67

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +15%

above

Price vs 50-day avg +14%

above

RSI (14) 60

neutral

MACD trend Positive

52-week position 84%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +28%

trailing

6-month return +12%

trailing

YTD return +9%

this year

Relative strength +3%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $20 › 200d $20 — 50d above 200d

Institutional flow Accumulating

8 of 246 funds reported for Jun 30 · net +142.0K sh shares

Insider flow Distributing

Net -$1.3M over 90 days · 100% sells

Short interest Rising

24.62% of float · ▲ +9.9% MoM · 8.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

246 holders — near 3-yr high, broad support

Squeeze score 86

high risk · 0–100

Fundamentals

Fair

Revenue growth +628%

Y/Y

EPS growth +12%

Y/Y

Free cash flow $-323.2M

Balance sheet $209.0M

net debt

Quant / Vol

risk profile

Very High

Volatility 57%

annualized · 1-yr

Max drawdown −32%

past year

ATR 5.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy

0 · 4 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+15% Bullish

Price vs 50-day avg

+14% Bullish

RSI (14)

60 Neutral

MACD trend

Positive Bullish

52-week position

84% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $20 › 200d $20 — 50d above 200d

Institutional flow Accumulating

8 of 246 funds reported for Jun 30 · net +142.0K sh shares

Insider flow Distributing

Net -$1.3M over 90 days · 100% sells

Short interest Rising

24.62% of float · ▲ +9.9% MoM · 8.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

246 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $9 Now $23 · 84% 52-wk high $26

vs 200-day avg +15% vs 50-day avg +14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Revuforj total prescriptions increase (4Q25 vs 3Q25)	35%	Q4 2025 vs Q3 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
SNDX Syndax Pharmaceuticals Inc this stock	$2.03B	+8.9%	+627.8%	—	24.6%
ONC BeOne Medicines Ltd.	$439.30B	+0.0%	+22179.2%	894.0	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$121.89B	+5.9%	+46.2%	28.5	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$69.52B	-14.0%	+20.8%	16.2	3.3%
ARGX Argenx SE	$54.76B	+4.2%	—	—	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

246

% held: 111.2%
Reported: 8 of 246
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

196

View

Short & Settlement

Short Interest Rising

Shares short

21.8M

Days to cover: 8.6d
Change: +2.0M sh

View

Short Volume

Short vol %

55%

As of: Jul 14, 2026

Short Total

View

Fails to Deliver

FTD shares

101.2K

Value: $1.8M
As of: Jun 5, 2026

View

Off-Exchange

Off-exchange %

52.9%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$1.3M

Buyers / Sellers: 0 / 3

Buyers Sellers

View

Financials

Revenue (FY)

$172.4M

Net income (FY): $-285.4M
EPS diluted: $-3.29

View

Filings

SEC Filings

Latest

8-K

Filed: Jul 14, 2026
This year: 10

View

Proposed Sales

Value

$752.4K

Shares: 32.4K
Filed: Jul 8, 2026

View

Earnings & Events

Earnings Calls

Last call

Apr 30, 2026

View

	5D	20D	120D	MTD	YTD
SNDX	+3.7%	+27.8%	+11.6%	+4.7%	+9.0%
SPY	-0.3%	+1.6%	+8.3%	+0.3%	+9.9%
vs SPY	+4.0%	+26.3%	+3.2%	+4.4%	-0.9%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance